Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation

Launched by HALIC UNIVERSITY ·

Keywords

ClinConnect Summary

This clinical trial is studying whether using virtual reality (VR) can help reduce physical and emotional symptoms in adults undergoing a type of stem cell transplant called allogeneic hematopoietic stem cell transplantation, often used to treat certain cancers and blood disorders. The study will compare patients who receive usual care with those who watch a specially designed, 15-minute nature-themed VR video during their stem cell infusion to see if the VR experience helps lower feelings of distress, anxiety, and other symptoms. Researchers will also look at how the VR might affect physical health measures and how quickly the new stem cells start working in the body.

Adults aged 65 to 74 who are going through this transplant procedure may be eligible to participate. Those who join will be randomly assigned to either the VR group or the standard care group. Everyone will complete simple assessments before and after the treatment to measure distress, anxiety, symptoms, and vital signs, and provide feedback about their experience. This study aims to find out if adding VR to usual care can make the transplant process more comfortable and less stressful for patients.

Gender

ALL

Eligibility criteria